AZN
NASDAQ
GB
AstraZeneca PLC - American Depositary Shares
$203,49
▲ +$2,76
(+1,38%)
Vol. 2.0M
11
Punteggio di Qualità
ok
Analisi approfondita
2/5
ok
Ricavi ✓
Utile netto ✓
>IPO ✗
Cap. mercato
$213.8B
P/E
30,6
ROE
21,8%
Margine
16,2%
D/E
71,11
Beta
0,86
Rendimento div.
1,77%
52W
$9574–$14206
Consenso Wall Street
36 analisti · Apr 202612
Acquisto forte
17
Compra
5
Mantieni
2
Vendi
0
Vendita forte
80,6%
Rating Compra
Grafico dei Prezzi
Utili
Tasso di battuta: 50,0%| Trimestre | EPS Stimato | EPS Effettivo | Sorpresa |
|---|---|---|---|
| Dic 2025 | $2,15 | $2,12 | $-0,03 |
| Set 2025 | $2,35 | $2,38 | +$0,03 |
| Giu 2025 | $2,35 | $2,17 | $-0,18 |
| Mar 2025 | $2,28 | $2,49 | +$0,21 |
Ricavi e utili trimestrali
| Trimestre | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… | 2025-1… |
|---|---|---|---|---|---|---|
| Ricavi | — | $14.9B | $13.6B | $14.5B | $15.2B | $15.5B |
| Utile netto | — | $1.5B | $2.9B | $2.5B | $2.5B | $2.3B |
Trend fondamentali
| Metrica | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | 19.8% | 19.8% | 19.8% | 19.8% | 21.8% | 21.8% |
| P/E (TTM) | 25.45 | 29.72 | 28.13 | 30.84 | 30.10 | 30.65 |
| Net Margin | 17.0% | 14.7% | 14.7% | 14.7% | 16.2% | 16.2% |
| Gross Margin | 82.0% | 82.1% | 82.1% | 82.1% | 81.9% | 81.9% |
| D/E Ratio | 73.43 | 73.43 | 73.43 | 73.43 | 71.11 | 71.11 |
| Current Ratio | 0.86 | 0.86 | 0.86 | 0.86 | 0.88 | 0.88 |
Rapporti chiave
ROA (TTM)
8,6%
P/S (TTM)
4,96
P/B
5,4
EPS (TTM)
$6,02
CF/Share
$5,82
Crescita ricavi 3A
+13,1%
52W High
$14206,00
52W Low
$9573,51
$9573,51
Intervallo 52 settimane
$14206,00
Salute finanziaria
Flusso di cassa libero
$1.1B
Debito netto
$23.9B
Liquidità
$5.7B
Debito totale
$29.6B
Aggiornato al Dic 31, 2025
Як AZN виглядає на тлі конкурентів у Pharmaceuticals?
Група порівняння: Large-cap Pharmaceuticals ($10B+) · 7 компаній
Оцінка AZN vs аналоги Pharmaceuticals
P/E
30,7
▲
68%
sopra
peer
(18,2)
vs Peer
vs Settore
Più costoso
P/S
5,0
▲
57%
sopra
peer
(3,2)
vs Peer
vs Settore
Sopravvalutato
P/B
5,4
▲
169%
sopra
peer
(2,0)
vs Peer
vs Settore
Sopravvalutato
Дивідендна дохідність
1,8%
▼
42%
sotto
peer
(3,1%)
vs Peer
vs Settore
Rendimento basso
Прибутковість AZN vs аналоги Pharmaceuticals
ROE
21,8%
▲
88%
sopra
peer
(11,6%)
vs Peer
vs Settore
Top livello
Net margin
16,2%
▼
12%
sotto
peer
(18,4%)
vs Peer
vs Settore
Debole
Валова маржа
81,9%
▲
13%
sopra
peer
(72,3%)
vs Peer
vs Settore
In linea
ROA
8,6%
▲
107%
sopra
peer
(4,2%)
vs Peer
vs Settore
Sotto media
Фінансове здоровʼя AZN vs аналоги Pharmaceuticals
D/E ratio
71,1
▲
0%
sopra
peer
(71,1)
vs Peer
vs Settore
In linea
Поточна ліквідність
0,9
▼
47%
sotto
peer
(1,7)
vs Peer
vs Settore
Liquidità bassa
Beta
0,9
▲
0%
sopra
peer
(0,9)
vs Peer
vs Settore
Meno volatile
Радар фундаменталів AZN
AZN
Mediana peer
Industria
AZN прибутковість vs борг
Розмір бульбашки = капіталізація · X = чиста маржа · Y = D/E ratio
AZN vs аналоги: ключові метрики
Dividendi
$6,28
/ anno
Feb 19, 2026
$2,1530
Ago 08, 2025
$1,0300
Feb 21, 2025
$2,1000
Ago 09, 2024
$1,0000
Feb 22, 2024
$1,9700
Ago 10, 2023
$0,9300
Feb 23, 2023
$1,9700
Ago 11, 2022
$0,9300